DEREK JANTZ - 07 Jun 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ John Alexander Kelly, Attorney-in-Fact for Derek Jantz
Issuer symbol
DTIL
Transactions as of
07 Jun 2022
Net transactions value
-$38,829
Form type
4
Filing time
09 Jun 2022, 16:42:23 UTC
Previous filing
07 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +29,545 +0.73% 4,061,824 07 Jun 2022 Direct F1, F2
transaction DTIL Common Stock Options Exercise +12,199 +0.3% 4,074,023 07 Jun 2022 Direct F1, F2
transaction DTIL Common Stock Sale $38,829 -18,849 -0.46% $2.06 4,055,174 08 Jun 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -29,545 -50% $0.000000 29,545 07 Jun 2022 Common Stock 29,545 Direct F2, F4
transaction DTIL Restricted Stock Units Options Exercise $0 -12,199 -33% $0.000000 24,391 07 Jun 2022 Common Stock 12,199 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2022.
F2 Each RSU represents a contingent right to receive one share of the Company's Common Stock.
F3 The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On June 7, 2021 the Reporting person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F5 On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.